6-hydroxychlorzoxazone has been researched along with Alloxan Diabetes in 3 studies
6-hydroxychlorzoxazone: chlorzoxazone metabolite in humans
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, HW | 1 |
| Bae, SK | 2 |
| Lee, MG | 2 |
| Sohn, YT | 1 |
| Ahn, CY | 1 |
| Jung, YS | 1 |
| Lee, I | 1 |
| Kim, YC | 1 |
| Shin, WG | 1 |
| Li, L | 1 |
| Zhang, Y | 1 |
3 other studies available for 6-hydroxychlorzoxazone and Alloxan Diabetes
| Article | Year |
|---|---|
Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
Topics: Animals; Biotransformation; Blood Proteins; Chlorzoxazone; Chromatography, High Pressure Liquid; Cyt | 2006 |
Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
Topics: Administration, Oral; Animals; Area Under Curve; Blood Proteins; Chlorzoxazone; Chromatography, High | 2008 |
[Changes of CYP2E1 activity in diabetic rat model].
Topics: Aniline Hydroxylase; Animals; Chlorzoxazone; Cytochrome P-450 CYP2E1; Diabetes Mellitus, Experimenta | 1998 |